Skip to content

Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer.

Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer. - integrated PET/CT for primary ovarian cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29961
Enrollment
20
Registered
2007-03-19
Start date
2006-06-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer ovarian neoplasm

Interventions

None listed

Sponsors

Academisch Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age > 18 years and suspicion of primary ovarian cancer based on the results of complaints, physical examination and findings from ultrasound

Exclusion criteria

Exclusion criteria: pregnancy, unwillingness to give informed medical consent, evidence of significant psychiatric disorder by history or exam, previous pelvic-abdominal surgery, radiotherapy within six months of study entry or chemotherapy.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the difference in ovarian carcinoma stage according to the International Federation of Gynecology and Obstetrics (FIGO), based on PET/CT and surgery/histological findings.

Secondary

MeasureTime frame
niet van toepassing

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)